Back to search
FDAFDA · Food and drugs·Recall number D-0611-2024

Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1203-03

Published July 24, 2024 · Recall initiated: June 26, 2024

Summary

FDA records drug Class II recall D-0611-2024, published July 24, 2024 and initiated June 26, 2024. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 142 blister cards, 30 per blister card; Lot: Lot #: J0758674-021824, Exp 03/31/2025; J0751898-011424, Exp 01/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Out of specification for dissolution

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
USA Nationwide
Lot
Lot #: J0758674-021824, Exp 03/31/2025; J0751898-011424, Exp 01/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1203-03 recalled?

Yes. FDA published recall D-0611-2024 on July 24, 2024. Reported hazard: CGMP Deviations: Out of specification for dissolution

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail